共 13 条
[1]
[Anonymous], 2002, JAMA
[2]
Should the NCEP III guidelines be change in elderly and younger persons at high risk for cardiovascular events?
[J].
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES,
2005, 60 (05)
:591-592
[3]
Long-term persistence in use of statin therapy in elderly patients
[J].
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION,
2002, 288 (04)
:455-461
[4]
Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
[J].
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION,
2001, 285 (19)
:2486-2497
[5]
Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3
[6]
Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels - Results of AFCAPS/TexCAPS
[J].
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION,
1998, 279 (20)
:1615-1622
[8]
Adherence with statin therapy in elderly patients with and without acute coronary syndromes
[J].
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION,
2002, 288 (04)
:462-467
[9]
Miettinen TA, 1997, CIRCULATION, V96, P4211
[10]
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA):: a multicentre randomised controlled trial
[J].
LANCET,
2003, 361 (9364)
:1149-1158